Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
Top Cited Papers
- 22 August 2000
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 102 (8) , 865-870
- https://doi.org/10.1161/01.cir.102.8.865
Abstract
Background—Plasma brain natriuretic peptide (BNP) level increases in proportion to the degree of right ventricular dysfunction in pulmonary hypertension. We sought to assess the prognostic signific...Keywords
This publication has 17 references indexed in Scilit:
- Reduction in Pulmonary Vascular Resistance with Long-Term Epoprostenol (Prostacyclin) Therapy in Primary Pulmonary HypertensionNew England Journal of Medicine, 1998
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: Relation to hemodynamic variables and endothelin levelsJournal of the American College of Cardiology, 1995
- Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension.Heart, 1993
- Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.Journal of Clinical Investigation, 1991
- Primary pulmonary hypertensionProgress in Cardiovascular Diseases, 1988
- A new natriuretic peptide in porcine brainNature, 1988
- Primary Pulmonary HypertensionAnnals of Internal Medicine, 1987
- Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP)Biochemical and Biophysical Research Communications, 1984
- Standardized Intracardiac Measurements of Two-Dimensional EchocardiographyJournal of the American College of Cardiology, 1983